Cite
HARVARD Citation
Baraliakos, X. et al. (n.d.). THU0398 Secukinumab sustains individual clinical responses over time in patients with active ankylosing spondylitis: 2-year results from a phase 3 trial, measure 2. Annals of the rheumatic diseases. p. 358. [Online].